Production (Stage)
Compugen Ltd.
CGEN
$1.64
-$0.02-1.21%
NASDAQ
| 12/31/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | ||
|---|---|---|---|---|---|
| Revenue | 1.47M | 6.70M | 2.56M | 33.46M | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | 1.47M | 6.70M | 2.56M | 33.46M | |
| Cost of Revenue | 675.00K | 1.55M | 2.10M | 2.00M | |
| Gross Profit | 796.00K | 5.15M | 457.00K | 31.46M | |
| SG&A Expenses | 2.37M | 2.38M | 2.54M | 2.54M | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | 8.95M | 10.11M | 11.05M | 15.48M | |
| Operating Income | -7.48M | -3.41M | -8.49M | 17.98M | |
| Income Before Tax | -6.11M | -2.11M | -7.26M | 18.72M | |
| Income Tax Expenses | 4.00K | 11.00K | 3.00K | 9.01M | |
| Earnings from Continuing Operations | -6.12M | -2.12M | -7.27M | 9.71M | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -6.12M | -2.12M | -7.27M | 9.71M | |
| EBIT | -7.48M | -3.41M | -8.49M | 17.98M | |
| EBITDA | -7.36M | -3.29M | -8.37M | 18.10M | |
| EPS Basic | -0.07 | -0.02 | -0.08 | 0.11 | |
| Normalized Basic EPS | -0.05 | -0.01 | -- | 0.13 | |
| EPS Diluted | -0.07 | -0.02 | -0.08 | 0.11 | |
| Normalized Diluted EPS | -0.05 | -0.01 | -- | 0.13 | |
| Average Basic Shares Outstanding | 89.54M | 89.53M | 89.51M | 88.42M | |
| Average Diluted Shares Outstanding | 89.54M | 89.53M | 89.51M | 88.42M | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |